Home Akcea Therapeutics

Akcea Therapeutics

acquired
IPO
Rare Disease Treatment Drug Developer
Basic
Enterprise Profile

Basic Information

Akcea Therapeutics is a biopharmaceutical company dedicated to helping patients with serious and rare diseases. Akcea, a subsidiary of Ionis Pharmaceuticals, has a strong portfolio of drugs in development and registration stages, covering a variety of targets and diseases using advanced RNA-targeted antisense therapies.
Akcea Therapeutics, Inc.
Boston,Massachusetts,United States of America
15~50 people
January 01, 2014
info@akceatx.com

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Gene Technology Biotechnology
Concept
Rare Diseases Therapeutic Products
Application Scenarios
Innovative Drugs Prescription Drug Nucleic Acid Drugs Small Nucleic Acid Drugs